Prognostic value of long non-coding RNA GHET1 in cancers: a systematic review and meta-analysis

Table 1 Basic characteristics of the included studies

Author	Year	Country	Sample size (n)	Cancer type	Cut-off value	Treatments	Outcomes	HR statistic	NOS
F. Yang	2014	China	42	GC	Median	Surgery	CP, OS	Survival curve	7
H. Liu	2018	China	86	ESCC	Median	Surgery	CP, OS	Survival curve	8
H.F. Liu	2017	China	55	ESCC	Median	Surgery	CP	NA	8
H.Y. Zhou	2017	China	64	PADC	NA	Surgery	CP	NA	8
J. Li	2017	China	179	HCC	NA	Surgery	CP, DFS, OS	Survival curve	8
L. Jin	2017	China	68	HCC	NA	Surgery	CP, OS	Survival curve	7
L.J. Li	2014	China	80	BLC	Median	Surgery	OS	Survival curve	7
Q.C. Zhang	2019	China	94	cervical cancer	Median	NA	CP, OS	Data in paper	7
Q.M. Shen	2018	China	105	NSCLC	Median	NA	CP, DFS, OS	Survival curve	7
R. Song	2018	China	60	BC	Median	Surgery	CP, OS	Survival curve	8
W. Yang	2018	China	60	osteosarcoma	Median	Surgery	CP, OS	Survival curve	7
W.J. Xie	2019	China	40	RCC	Median ratio	Surgery	CP	NA	8
Y. Xia	2016	China	42	GC	Median	Surgery	CP	NA	8
Y.P. Zhang1	2018	China	106	HCC	Median	Surgery	CP, DFS, OS	Survival curve	8
Y.P. Zhang2	2018	China	182	HCC	Median	Surgery	CP, DFS, OS	Data in paper	9
Z.B. Guan	2018	China	52	NSCLC	Median	Surgery	CP, OS	Data in paper	8

BC breast cancer, BLC bladder cancer, ESCC esophageal squamous cell carcinoma, GC gastric cancer, HCC hepatocellular carcinoma, PADC pancreatic cancer, NSCLC non-small lung cancer, qRT-PCR quantitative reverse transcription polymerase chain reaction, CP clinicopathological parameters, OS overall survival, DFS disease-free survival, NOS Newcastle–Ottawa Scale, NA not available

ISSN: 1475-2867